These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21987286)

  • 1. Rechallenge with temozolomide in recurrent glioma.
    Gaviani P; Silvani A; Lamperti E; Botturi A; Fariselli L; Simonetti G; Ferrari D; Salmaggi A
    Neurol Sci; 2011 Nov; 32 Suppl 2():S247-9. PubMed ID: 21987286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rechallenge with temozolomide in patients with recurrent gliomas.
    Wick A; Pascher C; Wick W; Jauch T; Weller M; Bogdahn U; Hau P
    J Neurol; 2009 May; 256(5):734-41. PubMed ID: 19240962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.
    Taal W; Segers-van Rijn JM; Kros JM; van Heuvel I; van der Rijt CC; Bromberg JE; Sillevis Smitt PA; van den Bent MJ
    J Neurooncol; 2012 May; 108(1):195-200. PubMed ID: 22396071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "One week on-one week off": efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center.
    Galldiks N; Berhorn T; Blau T; Dunkl V; Fink GR; Schroeter M
    J Neurooncol; 2013 Apr; 112(2):209-15. PubMed ID: 23299464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal role of temozolomide in the treatment of malignant gliomas.
    Stupp R; van den Bent MJ; Hegi ME
    Curr Neurol Neurosci Rep; 2005 May; 5(3):198-206. PubMed ID: 15865885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas.
    Tosoni A; Franceschi E; Ermani M; Bertorelle R; Bonaldi L; Blatt V; Brandes AA
    J Neurooncol; 2008 Sep; 89(2):179-85. PubMed ID: 18431544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New (alternative) temozolomide regimens for the treatment of glioma.
    Wick W; Platten M; Weller M
    Neuro Oncol; 2009 Feb; 11(1):69-79. PubMed ID: 18772354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.
    Perry JR; Rizek P; Cashman R; Morrison M; Morrison T
    Cancer; 2008 Oct; 113(8):2152-7. PubMed ID: 18756530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
    Quinn JA; Jiang SX; Reardon DA; Desjardins A; Vredenburgh JJ; Rich JN; Gururangan S; Friedman AH; Bigner DD; Sampson JH; McLendon RE; Herndon JE; Walker A; Friedman HS
    Neuro Oncol; 2009 Oct; 11(5):556-61. PubMed ID: 19289491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of various dose-dense regimens of temozolomide for recurrent high-grade glioma: a systematic review with meta-analysis.
    Wei W; Chen X; Ma X; Wang D; Guo Z
    J Neurooncol; 2015 Nov; 125(2):339-49. PubMed ID: 26334318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future developments in the use of temozolomide for the treatment of brain tumours.
    Stupp R; Gander M; Leyvraz S; Newlands E
    Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of temozolomide in recurrent malignant gliomas.
    Gaya A; Rees J; Greenstein A; Stebbing J
    Cancer Treat Rev; 2002 Apr; 28(2):115-20. PubMed ID: 12297119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
    Minniti G; Scaringi C; De Sanctis V; Lanzetta G; Falco T; Di Stefano D; Esposito V; Enrici RM
    J Neurooncol; 2013 Jan; 111(2):187-94. PubMed ID: 23129347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temozolomide dosing regimens for glioma patients.
    Strik HM; Marosi C; Kaina B; Neyns B
    Curr Neurol Neurosci Rep; 2012 Jun; 12(3):286-93. PubMed ID: 22437507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide in paediatric high-grade glioma: a key for combination therapy?
    Verschuur AC; Grill J; Lelouch-Tubiana A; Couanet D; Kalifa C; Vassal G
    Br J Cancer; 2004 Aug; 91(3):425-9. PubMed ID: 15266331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of temozolomide on immune response during malignant glioma chemotherapy.
    Sengupta S; Marrinan J; Frishman C; Sampath P
    Clin Dev Immunol; 2012; 2012():831090. PubMed ID: 23133490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling predicts response to temozolomide in malignant gliomas.
    Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E; Tsumoto K
    Int J Oncol; 2010 Jun; 36(6):1367-77. PubMed ID: 20428759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China.
    Wang HW; Xu ZK; Song Y; Liu YG
    Cancer Gene Ther; 2017 May; 24(5):215-220. PubMed ID: 28409559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.
    Wick A; Felsberg J; Steinbach JP; Herrlinger U; Platten M; Blaschke B; Meyermann R; Reifenberger G; Weller M; Wick W
    J Clin Oncol; 2007 Aug; 25(22):3357-61. PubMed ID: 17664483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.